Hexagon Nutrition: Chairman & Executive Director Arun Kelkar Completes Term
Mr. Arun Kelkar has completed his term as Chairman & Executive Director of Hexagon Nutrition Limited on September 28, 2026. The Board has acknowledged his contributions and leadership.
The departure of a Chairman and Executive Director upon completion of their term, without immediate replacement details provided, is considered a routine management change with a limited immediate impact on the company's operations or financials.
The announcement pertains to the completion of a term by a key management personnel, which is a routine event and does not inherently carry positive or negative financial implications.
Hexagon Nutrition Limited has announced the completion of Mr. Arun Kelkar's term as Chairman & Executive Director on September 28, 2026. The company's Board of Directors has expressed its sincere appreciation for Mr. Kelkar's dedicated service, guidance, and leadership since the company's inception.
The formal intimation was made to the National Stock Exchange of India Limited and BSE Limited, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further details regarding this change, as required by SEBI regulations and circulars, are provided in an accompanying annexure and will be available on the company's official website.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.